Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-8-7
|
pubmed:abstractText |
A pathogenetic role of the hepatitis C virus (HCV) has been hypothesized for a subset of B-cell non-Hodgkin's lymphomas (NHLs). However, the preliminary characterization of B-cell NHLs in HCV-infected individuals has been poorly addressed. In the present study, we report detailed information on 35 consecutive patients with overt B-cell NHL of recent onset and HCV infection; all patients referred to a single oncological center in Northeast Italy. Histopathologic evaluation was performed by a single reference hemopathologist, and the link with the two relevant autoimmune diseases predisposing to B-cell NHL and in which HCV has been implied, ie, "essential" mixed cryoglobulinemia (EMC) and Sjogren's syndrome, was investigated. Control groups included 122 consecutive HCV-negative patients with B-cell NHL and 464 consecutive histopathologic cases of B-cell NHL referred to the same center, as well as 127 consecutive patients with HCV infection and without lymphoma referred to a different center in the same geographical area. B-cell NHLs in HCV-infected patients frequently presented at onset (1) an extranodal localization with peculiar target organs of HCV infection (ie, the liver and major salivary glands) being significantly overrepresented; (2) a diffuse large cell histotype without any prior history of low-grade B-cell malignancy or bone marrow involvement; and (3) a weak association with a full-blown predisposing autoimmune disease, although serum autoimmune features were common and cryoglobulins were always present. Therefore, the HCV-related B-cell NHLs in this oncological series presented distinctive features compared with B-cell NHLs in HCV-negative patients, and they differed from bone marrow low-grade NHLs frequently diagnosed in HCV-positive patients with EMC. Such novel information may be relevant for future research aimed at clarifying the possible link between HCV infection, autoimmunity, nonmalignant B-cell lymphoproliferation, and overt B-cell malignancy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
776-82
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9226178-Aged,
pubmed-meshheading:9226178-Aged, 80 and over,
pubmed-meshheading:9226178-Antigens, CD,
pubmed-meshheading:9226178-Autoimmune Diseases,
pubmed-meshheading:9226178-Cryoglobulinemia,
pubmed-meshheading:9226178-Disease Susceptibility,
pubmed-meshheading:9226178-Female,
pubmed-meshheading:9226178-Hepatitis C,
pubmed-meshheading:9226178-Humans,
pubmed-meshheading:9226178-Immunophenotyping,
pubmed-meshheading:9226178-Italy,
pubmed-meshheading:9226178-Lymphoma, B-Cell,
pubmed-meshheading:9226178-Male,
pubmed-meshheading:9226178-Middle Aged,
pubmed-meshheading:9226178-Neoplasm Staging,
pubmed-meshheading:9226178-Sjogren's Syndrome
|
pubmed:year |
1997
|
pubmed:articleTitle |
Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection.
|
pubmed:affiliation |
Division of Experimental Oncology 1, Centro di Riferimento Oncologico, Aviano, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|